Uppsala University, Sweden
Han Liu, PhD student in Pharmacometrics, applied to oncology at the Department of Pharmacy, Uppsala University, Sweden. Current research focuses on (1) the dose optimization and individualization of tyrosine kinase inhibitors (TKIs) in patients with solid tumors, (2) integrated modeling of biomarker, survival, and safety in oncology drug development, and (2) multistate survival analysis applied in oncology.